Chris is an IBTA Senior Advisor. He lives in Wellington, New Zealand.

He assists primarily with monitoring the latest developments in brain tumour research and new therapies. He also manages the Events and Conferences page on the IBTA website, and oversees aspects of the IBTA’s social media activities. His special areas of interest include: genetic research; cancer metabolism; cancer immunotherapy; clinical trials; and access to new treatments.

Chris has represented the IBTA at international brain tumour conferences, including the Society for Neuro-Oncology (SNO) and the Asian Society of Neuro-Oncology (ASNO), and is a member of the the Co-operative Trials Group for Neuro-Oncology (COGNO, Australia). He is listed with the European Medicines Agency (EMA) as a patient expert in CNS tumours and with the European Organisation for Research and Treatment of Cancer (EORTC) for which he has reviewed patient information documentation and clinical trial protocols.

Chris gains inspiration from his wife, Lynda, a long term survivor of glioblastoma multiforme. When Lynda was first diagnosed in 2006, Chris was appalled at the lack of treatment options for brain tumour patients in his native New Zealand. Determined to overcome New Zealand’s small population and geographic isolation, Chris became an active participant on various online brain tumour forums, which eventually led to his involvement with the IBTA.

Chris completed a Bachelor of Engineering (Chemical and Materials) from the University of Auckland and then studied business and marketing at Massey University. He has over 28 years of commercial experience working principally in the food and beverage industries in New Zealand and Asia.